COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardiovascular complications while hospitalized, and more likely to die from COVID-19 infection, according to a new study published August 14, 2020 in the open-access journal PLOS ONE by Jolanda Sabatino of Universita degli Studi Magna Graecia di Catanzaro, Italy, and colleagues.
The Guerin Family Congenital Heart Program in the Smidt Heart Institute at Cedars-Sinai is expanding its surgical care for children and adult congenital heart disease patients by embarking on a new initiative that includes the expertise of the world-renowned Keck Medicine of USC heart surgery team.
The Comprehensive Stroke Center at MedStar Washington Hospital Center again has been recognized by the American Heart Association/American Stroke Association with its 2020 2020 Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award and Target: Stroke SM Honor Roll Elite, Target: Stroke Honor Roll Advanced Therapy and Target: Type 2 Diabetes Honor Roll Awards.
Stress-induced activity in the inferior frontal lobe of the brain may have a direct correlation with chest pain among people with coronary artery disease, according to new research released today in Circulation: Cardiovascular Imaging, an American Heart Association journal.
The Cardiovascular Research Foundation (CRF) will hold a free online seminar, “Get Heart Smart,” on August 24 hosted by Drs. Nisha Jhalani and Ajay Kirtane, renowned academic cardiologists from NewYork-Presbyterian/Columbia University Irving Medical Center. The seminar, part of a series of “Mini Med Schools” conducted by the CRF Women’s Heart Health Initiative, will focus on common heart disease symptoms, when to talk to your doctor, and when to seek emergency care.
Before lathering on the sunscreen and heading outdoors, it's important to know the signs of heat-related injuries and how to stay cool when the temperatures soar.
Each cigarette smoked a day by heavier smokers increases the risk of contracting some diseases by more than 30 per cent, according to a new international study published today.
Researchers at the University of Wisconsin–Madison have developed a method combining sticky nanoparticles with high-precision protein measurement to capture and analyze a common marker of heart disease to reveal details that were previously inaccessible.
Ann Apasewicz was hesitant to seek care at the height of the pandemic, but consulting her NYU Langone Hospital—Brooklyn doctor saved her life
The death rate for patients who experienced what is normally a lower-risk heart attack rose sharply during the peak of the COVID-19 pandemic in England, according to an analysis of NHS data.
Within a month following a heart attack, people are at increased risk for a second one. As a result, physicians treat these patients with medications to rapidly reduce cardiovascular risk factors for another event. Although statins are designed to reduce the risk from one underlying problem, low-density lipoprotein (LDL) or “bad” cholesterol, they often aren’t able drop it to recommended levels within 30 days. Now, testing a next-generation cholesterol-lowering drug known as a PCSK9 inhibitor, Johns Hopkins Medicine researchers showed they could lower blood cholesterol to safer levels faster when it is added to traditional therapies.
In a new study, investigators report that patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and remaining in normal sinus rhythm.
Three years after the ALLSTAR clinical trial ended prematurely, the study's data shows that treatments of cardiosphere-derived cells -- the same cells used as an experimental therapy tested in COVID-19 patients -- demonstrated unexpected promise in heart attack survivors. Downloadable video available.
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), in which the left ventricle of the heart is not able to relax enough to fill properly with blood, and HF with reduced ejection fraction (HFrEF), in which the left ventricle is not able contract enough to pump out as much blood.
From inflammation to heart failure, the effects the new coronavirus (COVID-19) could have on your heart are alarming, particularly as it relates to vigorous-intensity exercise, training and sporting activities.
In a pilot study of people living with HIV or high levels of cholesterol, Johns Hopkins Medicine researchers found that a six-week course of a cholesterol-lowering medication improved the function of the coronary arteries that provide oxygen to the heart.
DALLAS – June 22, 2020 – For decades, high-density lipoprotein (HDL) cholesterol has been dubbed “good cholesterol” because of its role in moving fats and other cholesterol molecules out of artery walls. People with higher HDL cholesterol levels tend to have lower rates of cardiovascular disease, studies have shown.
Pairing bariatric surgery with LVAD heart surgery may be an effective bridge to heart transplant for obese patients.
Cardiologist and heart failure expert Sean Pinney, MD, has been named co-director of the Heart & Vascular Center and director of the Advanced Heart Failure, Transplant and Mechanical Circulatory Support Program at the University of Chicago Medicine.
At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place. In a new study, LJI scientists show that certain T lymphocytes, a type of white blood cell, that start out trying to fight the disease can end up increasing inflammation and making atherosclerosis cases even worse.
For its lifesaving care of patients with severely injured hearts and lungs, University of Virginia Medical Center has earned the Extracorporeal Life Support Organization’s Platinum Level Center of Excellence Award, the international group’s highest honor. Fewer than 30 hospitals worldwide have earned this award.
A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world’s smallest, flexible scope for looking inside blood vessels.
While some hospitals paused or reduced organ transplants, MedStar Heart & Vascular Institute at MedStar Washington Hospital Center performed a record number of heart transplants during the height of the COVID-19 pandemic. Between March and May, 13 patients received new hearts–-more than double MedStar Heart & Vascular Institute’s typical volumes.
In an article published online on June 26 in the journal Heart Rhythm, lead author Raul Mitrani, M.D., and co-authors with the University of Miami Miller School of Medicine’s Division of Cardiovascular Medicine, examine the varied cardiovascular injuries and complications that patients who have recovered from the acute COVID-19 infection may experience largely based on evidence from other viral infections or inflammatory injury to the heart. The authors also recommend developing screening and tracking measures to detect cardiac injury and potentially mitigate long-term impact.
When seeking critical medical care, minutes count — especially when dealing with cases of suspected heart attack or stroke. Yet many patients in need of emergency care have delayed or avoided a trip to the hospital fearing possible infection with COVID-19.
Researchers have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available. A new study published in the journal Science Translational Medicine describes the drug and its delivery mechanisms and shows that the drug is also an effective treatment for heart attack in animal models.
In a groundbreaking new study, researchers at the University of Minnesota have 3D printed a functioning centimeter-scale human heart pump in the lab. The discovery could have major implications for studying heart disease, the leading cause of death in the United States killing more than 600,000 people a year.
• Ensures close connection between patient and physician for remote hypertension monitoring • Complements Mount Sinai’s growing telehealth initiative • Medicare-covered and generally at no cost to patients, depending on coverage
A drug used to treat systemic lupus erythematosus (SLE) significantly reduces the incidence of a rare and sometimes fatal heart condition in newborn babies, a new study from NYU Grossman School of Medicine researchers shows.
A compound commonly found in pickled capers has been shown to activate proteins required for normal human brain and heart activity, and may even lead to future therapies for the treatment of epilepsy and abnormal heart rhythms.
Breast Cancer patients are 60 percent more likely to die of cancer after surviving a heart attack, a new study finds.
An expert medical task force appointed by the American Medical Society for Sports Medicine (AMSSM) and National Federation of State High School Associations (NFHS) has issued guidance for assessing potential cardiac issues in high school student-athletes with COVID-19 infection.
Cleveland Clinic researchers have found a significant increase in patients experiencing stress cardiomyopathy, also known as broken heart syndrome, during the COVID-19 pandemic.
Current research indicates that unhealthy lifestyle choices along with emotional stressors like social are important risk factors for developing upper respiratory infections. It is possible these same factors also increase the risk of contracting COVID-19.
Young firefighter recruits who follow a ‘Mediterranean lifestyle’ are less likely to have hypertension (high blood pressure) and more likely to have good aerobic fitness, reports a study in the July Journal of Occupational and Environmental Medicine.
Scientists have discovered that one of the good bacteria found in the human gut has a benefit that has remained unrecognized until now: the potential to reduce the risk for heart disease.
A new COVID-19 Heart Program developed by cardiologists with the University of Miami Miller School of Medicine is addressing the varied heart issues stemming from the pandemic with comprehensive screenings and evaluations in a safe clinical setting. It also incorporates the latest findings from UM cardiology researchers studying how the coronavirus can affect the heart and its surrounding tissues.
New UCLA research conducted in mice could explain why some people suffer more extensive scarring than others after a heart attack. The study, published in the journal Cell, reveals that a protein known as type 5 collagen plays a critical role in regulating the size of scar tissue in the heart.
High-risk drinkers who substantially reduce their alcohol use can lower their risk of cardiovascular disease (CVD) despite not completely abstaining, according to study findings published in Alcoholism: Clinical and Experimental Research. CVD encompasses a range of conditions involving the heart or blood vessels, and is the leading cause of death in the US. It is also one of many negative health outcomes associated with heavy drinking and alcohol use disorder (AUD). Reductions in drinking can be defined using World Health Organization (WHO) ‘risk drinking levels’, which classify drinkers into ‘very high’, ‘high’, ‘moderate’ and ‘low’ risk categories based on their average daily alcohol consumption. Previous research has shown that a reduction of two or more levels (for example, from ‘very high’ to ‘moderate’) can lower the risk of multiple health issues, but did not assess the impact on CVD specifically. The latest study has examined associations between reductions in WHO risk drinking
New research from The University of Queensland has found that women who have hot flushes and night sweats after menopause are 70 per cent more likely to have heart attacks, angina and strokes.
A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus. The discovery, published today in the journal Cell Reports Medicine, was made using heart muscle cells that were produced by stem cell technology.
DALLAS – July 1, 2020 – A new report from cardiologists at UT Southwestern raises the hope that doctors will be able to visually check the jugular venous pressure of heart failure patients remotely, using the camera on a smartphone. The finding is especially timely as telemedicine expands during the pandemic.
After being defunded by a company with rights to its intellectual property, development of a pediatric heart-assist device has been revived at Cornell with the help of a $4.7 million grant from the U.S. Department of Defense.
MacNeal Hospital is the first hospital in Illinois to participate in a national, randomized clinical trial using daily vital signs and lung pressure measurement to manage patients with congestive heart failure (CHF). The PROACTIVE-HF trial utilizes a new monitoring system, coupled with a pressure sensor, implanted directly into a blood vessel in the lung. This system provides information that is recorded and transmitted over a cellular or Wi-Fi connection to a patient’s provider, allowing for medication changes, if necessary, to prevent further health deterioration or hospitalization.
Heart failure posed the greatest 5-year risk of death for people newly diagnosed with Type 2 diabetes than any other heart or kidney diseases, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Microorganisms on the tongue could help diagnose heart failure, according to research presented today on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC).1
In a heart attack, a series of biochemical processes leave the heart damaged, much like a car after an accident.
Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalized COVID-19 patients to suffer cardiac arrest or heart rhythm disorders, according to a new study. .
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right